Skip to main content
Videoconference and publication of the results for the 2020-2021 financial year, on June 16, 2021
June 1, 2021
Clinical trial conducted by MedinCell confirms the safety of continuous administration of ivermectin
April 19, 2021
MedinCell: mdc-CWM clinical phase 3 will start in 2021
March 25, 2021
Covid-19: MedinCell publishes an extensive Ivermectin Safety Expert Analysis
March 5, 2021
Tremendous success for MedinCell’s €30 million capital increase for qualified investors
February 11, 2021
MedinCell announces a capital increase of a c.€30 million
February 10, 2021
MedinCell announces three new products entering regulatory development
February 2, 2021
Publication of the 2021 financial calendar
February 1, 2021
MedinCell announces the transfer of its shares from compartment C to compartment B of Euronext Paris
January 28, 2021
